Pulmonology
3 New COPD Treatments Breathe New Life Into a Chronic Disease
Pulmonary care advances with biologics and inhaled options improving therapy for chronic obstructive lung disease.
JANUARY 23, 2026
ASHP Midyear Spotlights New COPD Treatments
COPD treatment options expand as new FDA-approved drugs—dupilumab, mepolizumab, and ensifentrine—offer ...
DECEMBER 8, 2025
Promise and Hurdles In Personalized Medicine
Only slightly more than one-third of people diagnosed with non-small cell lung cancer receive personalized ...
NOVEMBER 21, 2024
Biologics Hit Multiple Targets in Asthma and COPD
The future of pulmonary medicine is rapidly evolving, with biologic therapies hitting multiple targets in asthma ...
OCTOBER 26, 2024
Management of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension, a rare disease that falls under the larger umbrella of pulmonary hypertension, is ...
AUGUST 29, 2024
Weight-Loss Drug Could Cure Sleep Apnea in Up to Half of Obese Patients
The weight loss drug tirzepatide dramatically reduces obstructive sleep apnea (OSA), with about half of all ...
JUNE 21, 2024
Stigma Places Additional Emotional Burden on Lung Cancer Patients
Regardless of their smoking history, many lung cancer patients often feel stigmatized, which could affect their ...
MARCH 7, 2024
Using Data-Driven Monitoring Tools Boosts SP Outcomes
Vanderbilt Specialty Pharmacy has harnessed the power of patient monitoring tools to manage IBD, asthma and other ...
OCTOBER 13, 2023
Interplay Among Comorbidities, Insurance Coverage and Pneumonia in Children
Very young children with comorbidities as well as those who are on Medicaid develop more pneumococcal disease than ...
JULY 14, 2023
Pharmacist Involvement Improves Drug Adherence for Interstitial Lung Disease
Pharmacist involvement in an interdisciplinary program for the management of interstitial lung disease led to ...
JUNE 13, 2023
New Rx Option Breathes Some Life Into MAC Lung Disease
For the treatment of refractory MAC lung disease, Arikayce, first approved by the FDA in 2018, remains effective in ...
MAY 15, 2023
Part 2: Chapter 3: Pneumonia Diagnostics: The Pathway to Innovation
This Chapter is from Part 2: Leveraging Diagnostics to Bridge Pandemic Associated Antimicrobial Stewardship Gaps
NOVEMBER 22, 2022
